Density increase a marker of breast cancer risk during HRT
Change in mammographic density may be a useful intermediate marker of increased breast cancer risk in postmenopausal women using estrogen and progestin therapy (EPT). This was the finding of a case-controlled study conducted as part of the Women’s Health Initiative (WHI) study.